GRDN

Guardian Pharmacy Services, Inc.

29.66 USD
+0.02
0.07%
At close Updated Sep 15, 4:00 PM EDT
Pre-market
After hours
29.66
0.00
0%
1 day
0.07%
5 days
3.02%
1 month
25.57%
3 months
50.18%
6 months
44.33%
Year to date
49.12%
1 year
85.38%
5 years
85.38%
10 years
85.38%
 

About: Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

Employees: 3,400

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

1,100% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 3

200% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 15

69% more capital invested

Capital invested by funds: $230M [Q1] → $388M (+$158M) [Q2]

42% more funds holding

Funds holding: 74 [Q1] → 105 (+31) [Q2]

31.83% less ownership

Funds ownership: 111.89% [Q1] → 80.06% (-31.83%) [Q2]

Financial journalist opinion

Based on 3 articles about GRDN published over the past 30 days

Neutral
Business Wire
4 days ago
Guardian Pharmacy Services, Inc. to Participate in Upcoming Jefferies Healthcare Services Investor Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Jefferies Healthcare Services Conference in Nashville, TN, on Tuesday, September 30, 2025. The company will host investor meetings, and Fred Burke, Co-founder and Chief Executive Officer, will take part in a fireside chat with Jefferies analyst, Brian Tanquilut, at 3:35 p.m. CT (4:35 p.m. ET) the same day. A live audio webcast of the session will be available at https://invest.
Guardian Pharmacy Services, Inc. to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Positive
Zacks Investment Research
14 days ago
Guardian Pharmacy Services (GRDN)'s Technical Outlook is Bright After Key Golden Cross
Guardian Pharmacy Services, Inc. (GRDN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GRDN's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Guardian Pharmacy Services (GRDN)'s Technical Outlook is Bright After Key Golden Cross
Positive
Zacks Investment Research
21 days ago
Guardian Pharmacy (GRDN) Upgraded to Buy: What Does It Mean for the Stock?
Guardian Pharmacy (GRDN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Guardian Pharmacy (GRDN) Upgraded to Buy: What Does It Mean for the Stock?
Neutral
Business Wire
1 month ago
Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2025. Second Quarter Financial Results Revenue of $344.3 million, up 15% year-over-year, driven by low double-digit organic growth and acquisitions completed over the past 12 months. Resident count ended the quarter over 195,000, up 12% year-over-year. Net Income of $8.
Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance
Neutral
Business Wire
1 month ago
Guardian Pharmacy Services Strengthens Pacific Northwest Presence with Acquisition of Oregon-based Managed Healthcare Pharmacy
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Managed Healthcare Pharmacy, a leading long-term care pharmacy in Oregon.
Guardian Pharmacy Services Strengthens Pacific Northwest Presence with Acquisition of Oregon-based Managed Healthcare Pharmacy
Neutral
Business Wire
1 month ago
Guardian Pharmacy Services, Inc. to Report Second Quarter 2025 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) announced today that it will release its second quarter 2025 results on Monday, August 11, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants.
Guardian Pharmacy Services, Inc. to Report Second Quarter 2025 Financial Results and Host Conference Call
Neutral
Business Wire
3 months ago
Guardian Pharmacy of South Carolina Opens New Headquarters in Charleston to Support Statewide Growth
CHARLESTON, S.C.--(BUSINESS WIRE)--Winyah Pharmacy and Preferred Care rebrand as Guardian Pharmacy of South Carolina, and open new high-tech Charleston headquarters.
Guardian Pharmacy of South Carolina Opens New Headquarters in Charleston to Support Statewide Growth
Neutral
Business Wire
3 months ago
Guardian Pharmacy Services Expands Pacific Northwest Footprint with Acquisition of Washington-based Mercury Pharmacy Services
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) announced its acquisition of Mercury Pharmacy Services in Mountlake Terrace, Washington.
Guardian Pharmacy Services Expands Pacific Northwest Footprint with Acquisition of Washington-based Mercury Pharmacy Services
Neutral
Business Wire
3 months ago
Guardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common Stock
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the pricing of the previously announced underwritten public offering (the “Offering”) of 7,500,000 shares of its Class A common stock, at a public offering price of $21.00 per share, of which 6,059,553 shares will be sold by certain selling stockholders and 1,440,447 shares will be issued and sold by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In add.
Guardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common Stock
Neutral
Business Wire
3 months ago
Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the launch of a proposed underwritten public offering (the “Offering”) of 7,500,000 shares of its Class A common stock, consisting of 6,059,553 shares being offered by certain selling stockholders and 1,440,447 newly issued shares being offered by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the selling stockholders intend to grant the un.
Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock
Charts implemented using Lightweight Charts™